The firm's newly appointed regional leader, part of its latest addition in Philadelphia, will spearhead its expansion in the ...

Nick Setyan, Wedbush Securities managing director, joins CNBC's 'Power Lunch' to discuss how coffee's high trading price is ...

Research analysts at Wedbush lowered their FY2025 EPS estimates for shares of Plymouth Industrial REIT in a report released ...

Wedbush Securities, a global independent financial services firm, announces the hire of Mike McCall as Senior Vice President, Investments and Market M ...

Wedbush Securities boosted its price target on Outperform-rated Tesla ( NASDAQ: TSLA) to $400 after sizing up the U.S.

Wedbush Securities, a global independent financial services firm, proudly announces the continued expansion of our mainline ...

Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $4.00.

We recently published a list of 10 Trending AI Stocks on Latest Analyst Ratings and News. In this article, we are going to ...

Tesla shares continued to add to their gains since the presidential election on optimism the electric vehicle maker will benefit from a Trump administration.

Wedbush Securities’ Dan Ives believes a second Trump administration is a massive boost for Tesla's "full self-driving" ...